{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:50:22Z","timestamp":1769064622641,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00011-018-1161-8","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T02:49:22Z","timestamp":1527043762000},"page":"703-710","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Association of hyperhomocysteinemia with genetic variants in key enzymes of homocysteine metabolism and methotrexate toxicity in rheumatoid arthritis patients"],"prefix":"10.1007","volume":"67","author":[{"given":"Souhir","family":"Chaabane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meriam","family":"Messedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rim","family":"Akrout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariem","family":"Ben Hamad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouna","family":"Turki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameh","family":"Marzouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Keskes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zouheir","family":"Bahloul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Rebai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Ayedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdellatif","family":"Maalej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,23]]},"reference":[{"key":"1161_CR1","unstructured":"Imboden JB, Hellmann DB, Stone JH. Rheumatoid Arthritis: the disease diagnosis and clinical features. Current rheumatology diagnosis and treatment. NY: McGraw Hill; 2006. pp.\u00a0161\u20139."},{"key":"1161_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2010.10.001","author":"L Carmona","year":"2010","unstructured":"Carmona L, Cross M, Williams B, Lassere M, March L. Rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2010. \n                    https:\/\/doi.org\/10.1016\/j.berh.2010.10.001\n                    \n                  .","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1161_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/rheumatology\/keh088","volume":"43","author":"SL Whittle","year":"2004","unstructured":"Whittle SL, Hughes RA. Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review. Rheumatology. 2004;43:267\u201371","journal-title":"Rheumatology"},{"key":"1161_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0009-9120(98)00093-9","volume":"32","author":"A Hernanz","year":"1999","unstructured":"Hernanz A, Plaza A, Martin-Mola E, De Miguel E. Increased plasma levels of homocysteine and other thiol compounds in rheumatoid arthritis women. Clin Biochem. 1999;32:65\u201370.","journal-title":"Clin Biochem"},{"key":"1161_CR5","first-page":"875","volume":"29","author":"S W\u00e5llberg-Jonsson","year":"2002","unstructured":"W\u00e5llberg-Jonsson S, Cvetkovic JT, Sundqvist KG, Lefvert AK, Rantap\u00e4\u00e4-Dahlqvist S. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis. J Rheumatol. 2002;29:875\u201382.","journal-title":"J Rheumatol"},{"key":"1161_CR6","doi-asserted-by":"publisher","DOI":"10.1080\/13547500902730664","author":"C Fujimaki","year":"2009","unstructured":"Fujimaki C, Hayashi H, Tsuboi S, Matsuyama T, Kosuge K, Yamada H, et al. Plasma total homocysteine level and methylenetetrahydrofolate reductase 677C> T genetic polymorphism in Japanese patients with rheumatoid arthritis. Biomarkers. 2009. \n                    https:\/\/doi.org\/10.1080\/13547500902730664\n                    \n                  .","journal-title":"Biomarkers"},{"key":"1161_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111\u20133.","journal-title":"Nat Genet"},{"key":"1161_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0021-9150(00)00671-7","volume":"156","author":"IS Weisberg","year":"2001","unstructured":"Weisberg IS, Jacques PF, Selhub J, Bostom AG, Chen Z, Curtis Ellison R, et al. The 1298A\u2013>C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis. 2001;156:409\u201315.","journal-title":"Atherosclerosis"},{"key":"1161_CR9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00439-002-0779-2","volume":"111","author":"BN Trinh","year":"2002","unstructured":"Trinh BN, Ong CN, Coetzee GA, Yu MC, Laird PW. Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels. Hum Genet. 2002;111:299\u2013302.","journal-title":"Hum Genet"},{"key":"1161_CR10","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/art.1780400418","volume":"40","author":"R Roubenoff","year":"1997","unstructured":"Roubenoff R, Dellaripa P, Nadeau RM, Abad LW, Muldoon BA, Selhub J, et al. Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum. 1997;40:718\u201322.","journal-title":"Arthritis Rheum"},{"key":"1161_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1247\/csf.20.191","volume":"20","author":"N Horie","year":"1995","unstructured":"Horie N, Aiba H, Oguro K, Hojo H, Takishi K. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5\u2032-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct Funct. 1995;20:191\u20137.","journal-title":"Cell Struct Funct"},{"key":"1161_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1158\/1078-0432.CCR-1198-03","volume":"10","author":"A Paolo DI","year":"2004","unstructured":"DI Paolo A, Chu E. The role of thymidylate synthase as a molecular biomarker. Clin Cancer Res. 2004;10:411\u20132.","journal-title":"Clin Cancer Res"},{"key":"1161_CR13","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1093\/hmg\/5.12.1867","volume":"5","author":"D Leclerc","year":"1996","unstructured":"Leclerc D, Campeau E, Goyette P, Adjalla CE, Christensen B, Ross M, et al. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate\/cobalamin disorders. Hum Mol Genet. 1996;5:1867\u201374.","journal-title":"Hum Mol Genet"},{"key":"1161_CR14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s12026-014-8564-6","volume":"60","author":"VC Rom\u00e3o","year":"2014","unstructured":"Rom\u00e3o VC, Lima A, Bernardes M, Canh\u00e3o H, Fonseca JE. Three decades of low-dose methotrexate in rheumatoid arthritis: can we predict toxicity? Immunol Res. 2014;60:289\u2013310.","journal-title":"Immunol Res"},{"key":"1161_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/ard.58.2.79","volume":"58","author":"CJ Haagsma","year":"1999","unstructured":"Haagsma CJ, Blom HJ, van Riel PL, van\u2019t Hof MA, Giesendorf BA, van Oppenraaij-Emmerzaal D, et al. Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis. 1999;58:79\u201384.","journal-title":"Ann Rheum Dis"},{"key":"1161_CR16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1093\/rheumatology\/41.6.658","volume":"41","author":"AE Ede van","year":"2002","unstructured":"van Ede AE, Laan RF, Blom HJ, Boers GH, Haagsma CJ, Thomas CM, et al. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis. Rheumatology. 2002;41:658\u201365.","journal-title":"Rheumatology"},{"key":"1161_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/art.27201","author":"LK Stamp","year":"2010","unstructured":"Stamp LK, O\u2019Donnell JL, Chapman PT, Zhang M, James J, Frampton C, et al. Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy. Arthritis Rheum. 2010. \n                    https:\/\/doi.org\/10.1002\/art.27201\n                    \n                  .","journal-title":"Arthritis Rheum"},{"key":"1161_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/art.38113","author":"MC Rotte de","year":"2013","unstructured":"de Rotte MC, de Jong PH, Pluijm SM, Calasan MB, Barendregt PJ, van Zeben D, et al. Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate. Arthritis Rheum. 2013. \n                    https:\/\/doi.org\/10.1002\/art.38113\n                    \n                  .","journal-title":"Arthritis Rheum"},{"key":"1161_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315\u201324.","journal-title":"Arthritis Rheum"},{"key":"1161_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.138461","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/EuropeanLeague Against Rheumatism collaborative initiative. Arthritis Rheum. 2010. \n                    https:\/\/doi.org\/10.1136\/ard.2010.138461\n                    \n                  .","journal-title":"Arthritis Rheum"},{"key":"1161_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0021-9150(95)05648-3","volume":"119","author":"SS Kang","year":"1996","unstructured":"Kang SS, Wong PW. Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia. Atherosclerosis. 1996;119:135\u20138.","journal-title":"Atherosclerosis"},{"key":"1161_CR22","first-page":"298","volume":"11","author":"S Gustincich","year":"1991","unstructured":"Gustincich S, Manfioletti G, Del Sal G, Schneider C, Carninci P. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques. 1991;11:298\u2013300.","journal-title":"Biotechniques"},{"key":"1161_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-015-0288-z","author":"S Chaabane","year":"2016","unstructured":"Chaabane S, Marzouk S, Akrout R, Ben Hamad M, Achour Y, Rebai A, et al. Genetic determinants of methotrexate toxicity in Tunisian patients with rheumatoid arthritis: a study of polymorphisms involved in the MTX metabolic pathway. Eur J Drug Metab Pharmacokinet. 2016. \n                    https:\/\/doi.org\/10.1007\/s13318-015-0288-z\n                    \n                  .","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"1161_CR24","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/ng1669","volume":"37","author":"PI Bakker De","year":"2005","unstructured":"De Bakker PI, Yelensky R, Pe\u2019er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet. 2005;37:1217\u201323.","journal-title":"Nat Genet"},{"key":"1161_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2017.02.015","author":"TA Abd El-Aziz","year":"2017","unstructured":"Abd El-Aziz TA, Mohamed RH. Influence. MTHFR C677T gene polymorphism in the development of cardiovascular disease in Egyptian patients with rheumatoid arthritis. Gene. 2017. \n                    https:\/\/doi.org\/10.1016\/j.gene.2017.02.015\n                    \n                  .","journal-title":"Gene"},{"key":"1161_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0165-6147(00)01675-8","volume":"22","author":"PM Ueland","year":"2001","unstructured":"Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci. 2001;22:195\u2013201.","journal-title":"Trends Pharmacol Sci"},{"key":"1161_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2012.05.029","author":"RA Mahfouz","year":"2012","unstructured":"Mahfouz RA, Cortas NK, Charafeddine KM, Abdul Khalik RN, Sarieddine DS, Kadi RH, et al. Correlation of methylenetetrahydrofolate reductase polymorphisms with homocysteine metabolism in healthy Lebanese adults. Gene. 2012. \n                    https:\/\/doi.org\/10.1016\/j.gene.2012.05.029\n                    \n                  .","journal-title":"Gene"},{"key":"1161_CR28","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.gene.2013.06.041","volume":"527","author":"M Messedi","year":"2013","unstructured":"Messedi M, Frigui M, Chaabouni K, Turki M, Neifer M, Lahiyani A, et al. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and variations of homocysteine concentrations in patients with Behcet\u2019s disease. Gene. 2013;527:306\u201310.","journal-title":"Gene"},{"key":"1161_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.thromres.2005.04.009","volume":"117","author":"HJ Huh","year":"2006","unstructured":"Huh HJ, Chi HS, Shim EH, Jang S, Park CJ. Gene\u2013nutrition interactions in coronary artery disease: correlation between the MTHFR C677Tpolymorphism and folate and homocysteine status in a Korean population. Thromb Res. 2006;117:501\u20136.","journal-title":"Thromb Res"},{"key":"1161_CR30","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1136\/ard.2003.016337","volume":"63","author":"Y Berkun","year":"2004","unstructured":"Berkun Y, Levartovsky D, Rubinow A, Orbach H, Aamar S, Grenader T, et al. Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene. Ann Rheum Dis. 2004;63:1227\u201331.","journal-title":"Ann Rheum Dis"},{"key":"1161_CR31","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2016.160917","author":"W-X Li","year":"2017","unstructured":"Li W-X, Cheng F, Zhang A-Jie, Dai S-X, Li G-H, Lv W-W, et al. Folate deficiency and gene polymorphisms of MTHFR, MTR and MTRR elevate the hyperhomocysteinemia risk. Clin Lab. 2017. \n                    https:\/\/doi.org\/10.7754\/Clin.Lab.2016.160917\n                    \n                  .","journal-title":"Clin Lab"},{"key":"1161_CR32","first-page":"1664","volume":"34","author":"Y Berkun","year":"2007","unstructured":"Berkun Y, Abou Atta I, Rubinow A, Orbach H, Levartovsky D, Aamar S, et al. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis. J Rheumatol. 2007;34:1664\u20139.","journal-title":"J Rheumatol"},{"key":"1161_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbr.2014.12.001","author":"P Borman","year":"2015","unstructured":"Borman P, Ta\u015fba\u015f \u00d6, Karabulut H, Tukun A, Yorganc\u0131o\u011flu R. Thymidylate synthase genetic polymorphism and plasma total homocysteine level in a group of Turkish patients with rheumatoid arthritis: relationship with disease activity and methotrexate toxicity. Rev Bras Reumatol. 2015. \n                    https:\/\/doi.org\/10.1016\/j.rbr.2014.12.001\n                    \n                  .","journal-title":"Rev Bras Reumatol"},{"key":"1161_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000951.pub2","author":"B Shea","year":"2013","unstructured":"Shea B, Swinden MV, Tanjong Ghogomu E, Ortiz Z, Katchamart W, Rader T, et al. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev. 2013. \n                    https:\/\/doi.org\/10.1002\/14651858.CD000951.pub2\n                    \n                  .","journal-title":"Cochrane Database Syst Rev"},{"key":"1161_CR35","first-page":"441","volume":"25","author":"SL Morgan","year":"1998","unstructured":"Morgan SL, Baggott JE, Lee JY, Alarc\u00f3n GS. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention. J Rheumatol. 1998;25:441\u20136.","journal-title":"J Rheumatol"},{"key":"1161_CR36","doi-asserted-by":"publisher","DOI":"10.5606\/ArchRheumatol.2015.4249","author":"E Hayta","year":"2015","unstructured":"Hayta E, Hizmetli S, Haydar Atalar M, \u00c7inar Z. Association of plasma homocysteine level and carotid intima-media thickness in rheumatoid arthritis patients receiving methotrexate. Arch Rheumatol. 2015. \n                    https:\/\/doi.org\/10.5606\/ArchRheumatol.2015.4249\n                    \n                  .","journal-title":"Arch Rheumatol"},{"key":"1161_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/ard.2003.019828","volume":"64","author":"M Hoekstra","year":"2005","unstructured":"Hoekstra M, Haagsma CJ, Doelman CJA, Van de Laar MAFJ.. Intermittant rises in plasma homocysteine in patients with rheumatoid arthritis treated with higher dose methotrexate. Ann Rheum Dis. 2005;64:141\u20133.","journal-title":"Ann Rheum Dis"},{"key":"1161_CR38","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/rheumatology\/keh088","volume":"43","author":"SL Whittle","year":"2004","unstructured":"Whittle SL, Hughes RA. Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review. Rheumatol Oxf. 2004;43:267\u201371.","journal-title":"Rheumatol Oxf"},{"key":"1161_CR39","first-page":"859","volume":"25","author":"T Pettersson","year":"1998","unstructured":"Pettersson T, Friman C, Abrahamsson L, Nilsson B, Norberg B. Serum homocysteine and methylmalonic acid in patients with rheumatoid arthritis and cobalaminopenia. J Rheumatol. 1998;25:859\u201363.","journal-title":"J Rheumatol"},{"key":"1161_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/164_2016_107","author":"R Farr\u00e9","year":"2017","unstructured":"Farr\u00e9 R, Vicario M. Abnormal barrier function in gastrointestinal disorders. Handb Exp Pharmacol. 2017. \n                    https:\/\/doi.org\/10.1007\/164_2016_107\n                    \n                  .","journal-title":"Handb Exp Pharmacol"},{"key":"1161_CR41","first-page":"376","volume":"16","author":"FR Ponziani","year":"2012","unstructured":"Ponziani FR, Cazzato IA, Danese S, Fagiuoli S, Gionchetti P, Annicchiarico BE. Folate in gastrointestinal health and disease. Eur Rev Med Pharmacol Sci. 2012;16:376\u201385.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1161_CR42","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/ndt\/gfl044","volume":"21","author":"C Guldener van","year":"2006","unstructured":"van Guldener C. Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering? Nephrol Dial Transpl. 2006;21:1161\u20136.","journal-title":"Nephrol Dial Transpl"},{"key":"1161_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms3040866","author":"SB Singh","year":"2015","unstructured":"Singh SB, Lin HC. Hydrogen sulfide in physiology and diseases of the digestive tract. Microorganisms. 2015. \n                    https:\/\/doi.org\/10.3390\/microorganisms3040866\n                    \n                  .","journal-title":"Microorganisms"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00011-018-1161-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-018-1161-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-018-1161-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T01:47:42Z","timestamp":1558576062000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00011-018-1161-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,23]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1161"],"URL":"https:\/\/doi.org\/10.1007\/s00011-018-1161-8","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,23]]},"assertion":[{"value":"12 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}